Institutional Ownership Arcus Biosciences, Inc. (RCUS)
This table provides information about the institutional ownership of Arcus Biosciences, Inc. (RCUS). We have compiled data on the 206 institutions that hold shares in the stock, with a total of 67 Million shares, which have been reported (via 13F filing form) to have a value of $648 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,763,113
shares
|
$94.4 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.39%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
6,556,243
shares
|
$63.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.97%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
5,966,664
shares
|
$57.7 Million
0.11% of portfolio
|
Q2 2025
Added 108.11%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,000,029
shares
|
$38.7 Million
0.19% of portfolio
|
Q2 2025
Reduced 21.99%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
3,688,858
shares
|
$35.7 Million
1.03% of portfolio
|
Q2 2025
Added 44.05%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,630,815
shares
|
$35.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.78%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,659,879
shares
|
$16.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.61%
|
|
|
Invus Financial Advisors, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
1,612,077
shares
|
$15.6 Million
27.51% of portfolio
|
Q4 2021
Reduced 12.49%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
1,612,077
shares
|
$15.6 Million
0.68% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,596,329
shares
|
$15.4 Million
0.0% of portfolio
|
Q2 2025
Added 14.91%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,469,804
shares
|
$14.2 Million
0.0% of portfolio
|
Q2 2025
Added 86.74%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Aug 05, 2025 Q2 2025 |
1,395,726
shares
|
$13.5 Million
0.03% of portfolio
|
Q2 2025
Reduced 14.27%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,216,016
shares
|
$11.8 Million
0.67% of portfolio
|
Q2 2025
Added 17.18%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,136,364
shares
|
$11 Million
0.2% of portfolio
|
Q1 2025
New holding
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
936,021
shares
|
$9.05 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.56%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
869,790
shares
|
$8.41 Million
8.64% of portfolio
|
Q3 2023
New holding
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
805,305
shares
|
$7.79 Million
0.03% of portfolio
|
Q2 2025
Reduced 17.16%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
780,088
shares
|
$7.54 Million
0.0% of portfolio
|
Q2 2025
Reduced 34.7%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
776,742
shares
|
$7.51 Million
0.0% of portfolio
|
Q2 2025
Added 8.79%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
691,247
shares
|
$6.68 Million
0.0% of portfolio
|
Q2 2025
Added 21.26%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
648,074
shares
|
$6.27 Million
0.0% of portfolio
|
Q2 2025
Reduced 29.11%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
634,045
shares
|
$6.13 Million
0.02% of portfolio
|
Q2 2023
Reduced 50.61%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Aug 14, 2025 Q2 2025 |
627,626
shares
|
$6.07 Million
1.49% of portfolio
|
Q2 2025
Added 0.4%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
611,195
shares
|
$5.91 Million
0.0% of portfolio
|
Q2 2025
Added 62.08%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
599,610
shares
|
$5.8 Million
0.65% of portfolio
|
Q2 2025
Reduced 50.67%
|